Dose of Labeled Cholesterol for Kinetics: A Pilot Study
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 13-004890
NCT ID: NCT02065817
Sponsor Protocol Number: 13-004890
About this study
This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Healthy men and women ages 18 - 50
Exclusion Criteria:
- Cardiovascular disease
- Metabolic disease
- Hematologic disorder
- Liver or kidney disease
- phenylketonuria
- Currently taking lipid lowering medications or any other drugs that could affect lipid metabolism
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Ananda Basu, M.B.B.S., M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available